Paper20175036
Mouse models of hepatocellular carcinoma.
Fausto N and 1 other. Semin Liver Dis, 2010. Cited by 85 papers, by iCite.
Cite this record
ConductScience Library. Mouse models of hepatocellular carcinoma. Papers, record 20175036. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20175036
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Review
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms, Experimental | Major topic |
| Animals | |
| Cell Transformation, Neoplastic | |
| Disease Models, Animal | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Mice | |
| Mice, Knockout | |
| Mice, Transgenic | |
| Species Specificity |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA127228 | NCI NIH HHS | United States | R01CA127228 | PubMed and NIH | NIH RePORTER |
| CA23226 | NCI NIH HHS | United States | R01CA023226 | PubMed and NIH | NIH RePORTER |
| CA74131 | NCI NIH HHS | United States | R01CA074131 | PubMed and NIH | NIH RePORTER |
| R37CA023226 | NIH | NIH RePORTER |
Cited by55
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 85 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41710699 | Electroacupuncture and Moxibustion Regulate Aerobic Glycolysis and Alleviate Tumor Progression in Mice with Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2026 | https://conductscience.org/library/papers/41710699 | PubMed |
| 40219344 | Chitosan-Folic Acid-Coated Quercetin-Loaded PLGA Nanoparticles for Hepatic Carcinoma Treatment. | Polymers (Basel) | 2025 | https://conductscience.org/library/papers/40219344 | PubMed |
| 39877003 | Development of novel nucleic acid therapy aimed at directly controlling liver fibrosis. | Mol Ther Nucleic Acids | 2025 | https://conductscience.org/library/papers/39877003 | PubMed |
| 36765862 | SOCS1 Deficiency Promotes Hepatocellular Carcinoma via SOCS3-Dependent CDKN1A Induction and NRF2 Activation. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36765862 | PubMed |
| 35847898 | Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application. | Front Oncol | 2022 | https://conductscience.org/library/papers/35847898 | PubMed |
| 35463072 | Polysaccharide-Rich Fractions from Ganoderma resinaceum (Ganodermataceae) as Chemopreventive Agents in N-Diethylnitrosamine-Induced Hepatocellular Carcinoma in Wistar Rats. | Evid Based Complement Alternat Med | 2022 | https://conductscience.org/library/papers/35463072 | PubMed |
| 35243280 | Cellular origins of regenerating liver and hepatocellular carcinoma. | JHEP Rep | 2022 | https://conductscience.org/library/papers/35243280 | PubMed |
| 34370903 | The DEN and CCl4 -Induced Mouse Model of Fibrosis and Inflammation-Associated Hepatocellular Carcinoma. | Curr Protoc | 2021 | https://conductscience.org/library/papers/34370903 | PubMed |
| 33796224 | Characterization of the inflammatory microenvironment and hepatic macrophage subsets in experimental hepatocellular carcinoma models. | Oncotarget | 2021 | https://conductscience.org/library/papers/33796224 | PubMed |
| 32884988 | Study on the hepatocellular carcinoma model with metastasis. | Genes Dis | 2020 | https://conductscience.org/library/papers/32884988 | PubMed |
| 32823526 | Genetically Engineered Mouse Models of Liver Tumorigenesis Reveal a Wide Histological Spectrum of Neoplastic and Non-Neoplastic Liver Lesions. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32823526 | PubMed |
| 32807134 | Prognostic significance of SOCS1 and SOCS3 tumor suppressors and oncogenic signaling pathway genes in hepatocellular carcinoma. | BMC Cancer | 2020 | https://conductscience.org/library/papers/32807134 | PubMed |
| 31979130 | Animal Modeling of Pediatric Liver Cancer. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/31979130 | PubMed |
| 31572672 | Non-invasive Bioluminescence Monitoring of Hepatocellular Carcinoma Therapy in an HCR Mouse Model. | Front Oncol | 2019 | https://conductscience.org/library/papers/31572672 | PubMed |
| 31571927 | Intratumoral IL-12 Gene Therapy Inhibits Tumor Growth In A HCC-Hu-PBL-NOD/SCID Murine Model. | Onco Targets Ther | 2019 | https://conductscience.org/library/papers/31571927 | PubMed |
| 30898969 | Characterization of high- and low-risk hepatocellular adenomas by magnetic resonance imaging in an animal model of glycogen storage disease type 1A. | Dis Model Mech | 2019 | https://conductscience.org/library/papers/30898969 | PubMed |
| 29850590 | Diethylnitrosamine Increases Proliferation in Early Stages of Hepatic Carcinogenesis in Insulin-Treated Type 1 Diabetic Mice. | Biomed Res Int | 2018 | https://conductscience.org/library/papers/29850590 | PubMed |
| 28710407 | Role of insulin receptor substrates in the progression of hepatocellular carcinoma. | Sci Rep | 2017 | https://conductscience.org/library/papers/28710407 | PubMed |
| 28262799 | Dietary restriction protects against diethylnitrosamine-induced hepatocellular tumorigenesis by restoring the disturbed gene expression profile. | Sci Rep | 2017 | https://conductscience.org/library/papers/28262799 | PubMed |
| 28256571 | Environmental exposures as a risk factor for fibrolamellar carcinoma. | Mod Pathol | 2017 | https://conductscience.org/library/papers/28256571 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20175036
GET https://conductscience.org/api/papers/v1/20175036/cited_by?page=2